1-4 of 4
Melissa Lock
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Pathogenesis of Therapy-Related Myeloid Neoplasms from TP53 -Mutant Clonal Hematopoiesis

Jonas Fullin, Ebru Topçu, Roman R. Schimmer, Nancy Klemm, Karolina Zielinska, Christian Koch, Francisco Caiado, Cyril Doerdelmann, Melissa Lock, Joelle Tchinda, Markus G. Manz, Massimo Lopes, Steffen Boettcher
Journal: Blood
Blood (2024) 144 (Supplement 1): 41.
https://doi.org/10.1182/blood-2024-205209
Published: 2024
Journal Articles

Somatic TP53 Mutations Rescue the Hematopoietic Stem and Progenitor Cell Defect at the Expense of Increased Risk for Myeloid Malignancies in ERCC6L2 -Associated Inherited Bone Marrow Failure Syndrome

Roman R. Schimmer, Nancy Klemm, Ebru Topçu, Jonas Fullin, Karolina Zielinska, Cyril Doerdelmann, Melissa Lock, Milena Treacy, Francisco Caiado, Nadja Dietliker, Rahel Schwotzer, Markus G. Manz, Massimo Lopes, Steffen Boettcher
Journal: Blood
Blood (2024) 144 (Supplement 1): 193.
https://doi.org/10.1182/blood-2024-204925
Published: 2024
Journal Articles

Loss of Dnmt3a increases self-renewal and resistance to pegIFN-α in JAK2 -V617F–positive myeloproliferative neoplasms

Marc Usart, Jan Stetka, Damien Luque Paz, Nils Hansen, Quentin Kimmerlin, Tiago Almeida Fonseca, Melissa Lock, Lucia Kubovcakova, Riikka Karjalainen, Hui Hao-Shen, Anastasiya Börsch, Athimed El Taher, Jessica Schulz, Jean-Christophe Leroux, Stefan Dirnhofer, Radek C. Skoda
Journal: Blood
Blood (2024) 143 (24): 2490–2503.
https://doi.org/10.1182/blood.2023020270
Published: 2024
Includes: Supplemental data
Journal Articles

Combination of 5-Azacytidine and Pegifna Is Able to Overcome Resistance in JAK2 -V617F Positive MPN with Loss of Dnmt3a

Melissa Lock, Damien Luque Paz, Nils Hansen, Tiago Almeida Fonseca, MARC Usart, Shivam Rai, Hui Hao-Shen, Gabriele Mild, Stephan Dirnhofer, Radek C. Skoda, Jan Stetka
Journal: Blood
Blood (2022) 140 (Supplement 1): 3876–3877.
https://doi.org/10.1182/blood-2022-167002
Published: 2022